Pre-clinical development of the human CD40 agonistic antibody ADC-1013

Similar Items

• ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
  od: Mangsbo, Sara M, i dr.
  Izdano: (2013)
• The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
  od: Mangsbo, Sara M, i dr.
  Izdano: (2014)
• Kick-starting the cancer-immunity cycle by targeting CD40
  od: Ellmark, P, i dr.
  Izdano: (2015)
• Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
  od: Ellmark, Peter, i dr.
  Izdano: (2016)
• Pre-assembly of the extracellular domains of CD40 is not necessary for rescue of mouse B cells from anti-immunoglobulin M-induced apoptosis
  od: Ellmark, Peter, i dr.
  Izdano: (2003)